Thursday, January 20, 2011
The five-year collaboration will join
researchers with CTC technology expertise from the MGH BioMicroElectroMechanical
Systems (BioMEMS) Resource Center, clinical researchers and molecular
biologists from the hospital's Cancer Center and R&D staff from two J&J
units-Veridex and the Ortho Biotech Oncology R&D unit.
Martz, L. SciBX
Published online Jan. 20, 2010
Medical School, Boston, Mass.
Johnson & Johnson (NYSE:JNJ), New
General Hospital, Boston, Mass.
Institute of Technology, Cambridge, Mass.